Why is Par Drugs & Che. falling/rising?

As of 05-Jun, Par Drugs & Chemicals Ltd is experiencing a price increase, with the current price at 100.51, reflecting a change of 0.99 (0.99%) upward. The stock's performance today is in line with its sector, although it is trading higher than the 50-day moving average but lower than the 5-day, 20-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 1.47%, and it has seen a significant drop of 55.29% over the past year, indicating a poor long-term performance. Despite this, the company has a low debt-to-equity ratio and an attractive valuation with a return on equity of 13.8 and a price-to-book value of 1.3, suggesting that it is trading at a discount compared to its peers.
In the broader market context, the stock's short-term return has underperformed the benchmark, with the Sensex showing a decline of only 0.33% over the past week. The company's negative results, including a significant drop in profit after tax and net sales, contribute to a bearish outlook, as indicated by various technical indicators. The long-term growth prospects appear poor, with net sales and operating profit growing at low rates over the past five years. Overall, while there is a slight uptick in the stock price today, the underlying fundamentals and recent performance suggest ongoing challenges for Par Drugs & Chemicals Ltd.